Allurion Technologies Inc. (ALUR)
NYSE: ALUR · Real-Time Price · USD
2.170
-0.050 (-2.25%)
At close: Aug 29, 2025, 4:00 PM
2.130
-0.040 (-1.84%)
After-hours: Aug 29, 2025, 4:12 PM EDT
Company Description
Allurion Technologies Inc. focuses on ending obesity with a weight loss platform to treat people who are overweight.
Its platform offers the Allurion Program, a swallowable and procedure-less intragastric balloon for weight loss, as well as provides access to artificial intelligence-powered remote patient monitoring tools, a proprietary behavior change program, secure messaging, and video telehealth that are delivered by the Allurion Virtual Care Suite.
The company operates in Spain, France, Turkey, and internationally. Allurion Technologies Inc. is headquartered in Natick, Massachusetts.
Allurion Technologies Inc.
| Country | United States |
| Founded | 2009 |
| Industry | Medical Devices |
| Sector | Healthcare |
| Employees | 137 |
| CEO | Shantanu Gaur |
Contact Details
Address: 11 Huron Drive Natick, Massachusetts 01760 United States | |
| Phone | 508 647 4000 |
| Website | allurion.com |
Stock Details
| Ticker Symbol | ALUR |
| Exchange | NYSE |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001964979 |
| CUSIP Number | 02008G102 |
| ISIN Number | US02008G2012 |
| SIC Code | 3841 |
Key Executives
| Name | Position |
|---|---|
| Dr. Shantanu K. Gaur M.D. | Co-Founder, Chief Executive Officer, President, Principal Financial and Accounting Officer and Director |
| Ojas A. Buch | Chief Operating Officer |
| Brendan Michael Gibbons J.D. | Chief Legal Officer and Corporate Secretary |
| Dr. Samuel G. Levy | Co-Founder |
| Dr. Ram Chuttani M.D. | MD, Chief Medical Officer and Founding Partner |
| Matt Wright | Vice President of People |
| Adrian Wild | Senior Vice President of International Commercial |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Aug 28, 2025 | 10-Q/A | [Amend] Quarterly report |
| Aug 28, 2025 | 10-Q/A | [Amend] Quarterly report |
| Aug 28, 2025 | 10-Q/A | [Amend] Quarterly report |
| Aug 28, 2025 | 10-K/A | [Amend] Annual report |
| Aug 21, 2025 | 424B3 | Prospectus |
| Aug 21, 2025 | 424B3 | Prospectus |
| Aug 21, 2025 | 424B3 | Prospectus |
| Aug 21, 2025 | 424B3 | Prospectus |
| Aug 19, 2025 | 10-Q | Quarterly Report |
| Aug 19, 2025 | 10-Q/A | [Amend] Quarterly report |